News

A study conducted by Antidote Technologies and SCORR Marketing looks at what patient centricity means in clinical trials and the work that remains to realize the potential for better study designs.

Database integration initiatives in the biopharmaceutical industry is now enabling clinical development departments to leverage that data for enhancing decision-making.

Medidata and Cognizant enter into a strategic alliance to offer clients comprehensive solutions that leverage Mediata's cloud platform with Cognizant's business and technology services.

The FDA proposes to use the RWE Program to guide generation of data in support of approval for new indications or to help support post-approval study requirements.